Moexipril Hydrochloride
NDC 62135-969, Moexipril Hydrochloride, tablet, film coated, from Chartwell RX, LLC.
- Product NDC
- 62135-969
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077536
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-969 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MOEXIPRIL HYDROCHLORIDE15 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-969-90 | 62135096990 | 90 TABLET, FILM COATED in 1 BOTTLE (62135-969-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5c24072c-9769-4cb5-b8da-bf814d21391dNADAC price for package 62135096990
GET /v1/drugs/nadac/62135096990
Use it
Look up 62135-969 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-969 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-969. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.